PTGS2 and neoplasm: The group solved the challenge of pharmacokinetic differences and the spatial barrier that PD-1/PD-L1 interaction occurred outside the cell while COX-2 was located intracellularly: this intelligent nanoparticle could release celecoxib (COX-2 inhibitor) in cells in response to the elevated GSH concentration inside tumor cells.